98%
921
2 minutes
20
Focal cortical dysplasia (FCD) is a major cause for drug-resistant epilepsies. The molecular and cellular mechanisms of epileptogenesis in FCD are still poorly understood. Some studies have suggested that deficiencies of γ-aminobutyric acid (GABA) system may play an important role in type II FCD, but it remains controversial. In order to examine whether and how GABAergic interneurons and synaptic function are affected, we generated a somatic mTOR hyperactivation-based mouse model of type II FCD by in utero electroporation, quantified densities of interneurons in the malformed cortices, and recorded miniature inhibitory postsynaptic currents in dysmorphic neurons. We detected 20-25% reduction of GABAergic interneurons within malformed cortices, independent of cortical regions and cell subtypes but proportionate to the decrease of global neuron counts. GABAergic synaptic transmission from interneurons to mTOR hyperactivated dysmorphic neurons was dramatically disrupted, outweighing the decrease of interneuron counts. Postnatal mTOR inhibition partially rescued these alterations of GABAergic system. We also quantified the expression of GABA receptor, GABA transporter, and chloridion transporter encoding genes and found that their expression was relatively intact within the malformed cortices. Taken together, these results confirmed that GABAergic interneuron and synapse transmission are disturbed profoundly in an mTOR-dependent manner in type II FCD. Our study suggests that postsynaptic mechanisms independent of interneuron reduction or altered expression of GABA synapse genes might be accountable for the impaired GABAergic neurotransmission in type II FCD as well as other mTOR-related epilepsies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12035-020-02086-y | DOI Listing |
Life (Basel)
August 2025
Third Department of Neurology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Background: Functional Neurological Disorder (FND) encompasses a spectrum of symptoms-including motor, cognitive, and seizure-like manifestations-that are not fully explained by structural neurological disease. Accumulating evidence suggests that comorbid psychiatric and somatic conditions significantly influence the clinical course, diagnostic complexity, and treatment response in FND.
Objective: This study systematically explores psychiatric and medical comorbidities across major FND subtypes-Functional Cognitive Disorder (FCD), Functional Movement Disorder (FMD), and Psychogenic Non-Epileptic Seizures (PNES)-with an emphasis on subtype-specific patterns and shared vulnerabilities.
Int J Biol Macromol
August 2025
Key Laboratory of Tobacco Chemistry, Zhengzhou Tobacco Research Institute, CNTC, Zhengzhou 450001, China. Electronic address:
This study aimed to elucidate the anticancer mechanism of Fucoidan (FCD) in Benzo(a)pyrene (B(a)P)-induced lung cancer, especially its effect on club stem cells. C57BL/6 wild-type mice received intratracheal instillations of B(a)P (1 mg/mouse) weekly for 4 consecutive weeks to establish an animal model of lung cancer. FCD interventions were administered ad libitum via drinking water.
View Article and Find Full Text PDFInflammopharmacology
August 2025
Department of Material Science and Engineering, Faculty of Engineering, Eskisehir Technical University, Eskisehir, Turkey.
Objective: Osteoarthritis (OA) is a chronic, degenerative joint disease characterized by cartilage breakdown, inflammation, and progressive loss of joint function, leading to significant disability and reduced quality of life. Current treatment strategies, including pharmacological agents and intra-articular (IA) injections such as corticosteroids and hyaluronic acid (HA), provide symptomatic relief but fail to halt disease progression or promote cartilage regeneration. This study investigates the therapeutic potential of novel injectable hybrid hydrogels composed of hexagonal boron nitride (hBN) nanoparticles (NP) and nanosheets (NS) combined with HA.
View Article and Find Full Text PDFSci Rep
August 2025
Department of Radiology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Focal cortical dysplasia (FCD) is the leading cause of drug-resistant epilepsy (DRE) in pediatric patients. Accurate detection of FCDs is crucial for successful surgical outcomes, yet remains challenging due to frequently subtle MRI findings, especially in children, whose brain morphology undergoes significant developmental changes. Automated detection algorithms have the potential to improve diagnostic precision, particularly in cases, where standard visual assessment fails.
View Article and Find Full Text PDFFunctional Cognitive Disorder ("FCD") is a type of Functional Neurological Disorder characterised by subjective cognitive complaints not fully attributable to brain injury, disease, or other neuropathological or psychiatric conditions. FCD is a cognitive impairment but does not necessarily "convert" to cognitive decline. However, FCD is common in Memory Clinics worldwide, and currently there is a lack of tests to objectively assess FCD.
View Article and Find Full Text PDF